Long-term supplementation with n-3 fatty acids, I: effect on blood lipids, haemostasis and blood pressure

References

• Ross R. The pathogenesis of atherosclerosis—an update. N Engl J Med 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Antiplatelet trialists' collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988; 296: 320–31
   PubMed Web of Science ®Google Scholar
• Meade T W, Brozovic M, Chakrabarti R R, Haines A P, Imcson J D, Mellows S, Miller G J, North W RS, Stirling Y, Thompson S G. Haemostatic function and ischacmic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; i: 533–7
   Google Scholar
• Kannel W B, Wolf P A, Castclli W P, D'Agostino R B. Fibrinogen and risk of cardiovascular disease. JAMA 1987; 258: 1183–6
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5
   PubMed Web of Science ®Google Scholar
• Balleisen L, Schulte M, Assmann G, Epping P-H, Van de Loo J. Coagulation factors and the progress of coronary heart disease. Lancet 1987; ii: 461
   Google Scholar
• Hamsten A, Blombäck M, Wiman B, Svensson J, Szamosi A, De Faire U, Mettinger L. Haemostatic function in myocardial infarction. Br Heart J 1986; 55: 58–66
   PubMedGoogle Scholar
• Paramo J A, Colucci M, Collen D, van de Werf F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J 1985; 291: 573–4
   PubMed Web of Science ®Google Scholar
• Hamsten A, Walldius G, Szamosi A, Blombäck M, De Faire U, Dahlèn G, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; ii: 3–9
   Google Scholar
• Olofsson B O, Dahlèn G, Nilsson T K. Evidence for increased levels of tissue plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J 1989; 10: 77–82
   PubMed Web of Science ®Google Scholar
• Kromhout D, Bosschieter E B, De Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205–9
   PubMed Web of Science ®Google Scholar
• Burr M L, Fehily A M, Gilbert J F, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; ii: 757–61
   Google Scholar
• Kromhout D. n-3 fatty acids and coronary heart disease: epidemiology from Eskimos to western populations. J Intern Med 1989; 225(Suppl. 1)47–51
   PubMedGoogle Scholar
• Leaf A, Weber P C. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318: 549–57
   PubMed Web of Science ®Google Scholar
• Nordøy A, Goodnight S H. Dietary lipids and thrombosis. Relationships to atherosclerosis. Arteriosclerosis 1990; 10: 149–63
   PubMedGoogle Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Kristensen S D, Schmidt E B, Andersen H R, Dyerberg J. Fish oil in angina pectoris. Atherosclerosis 1987; 64: 13–9
   PubMed Web of Science ®Google Scholar
• Schmidt E B, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemostas 1990; 63: 1–5
   PubMed Web of Science ®Google Scholar
• Clauss A. Gerinnungsphysiologische schnellmetode zur bestimmung des fibrinogens. Acta Haematol 1957; 17: 237–46
   PubMedGoogle Scholar
• Chmielewska J, Wiman B. Determination of tissue plasminogen activator and its ‘fast’ inhibitor in plasma. Clin Chem 1986; 32: 482–5
   PubMed Web of Science ®Google Scholar
• Ränby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986; 32: 2160–5
   PubMed Web of Science ®Google Scholar
• Cejka J. Enzyme immunoassay for factor VIII-related antigen. Clin Chem 1982; 28: 1356–8
   PubMed Web of Science ®Google Scholar
• Rahe A J. Tables of critical values for the Pratt matched pair signed rank statistic. J Am Stat Assoc 1974; 69: 368–73
   Web of Science ®Google Scholar
• Siegel S, Castellan N J, Jr. Nonparametric Statistics for the Behavioural Sciences. McGraw-Hill, New York 1988
   Google Scholar
• Singer P, Berger I, Lück K, Taube C, Naumann E, Gödicke W. Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 1986; 62: 259–65
   PubMed Web of Science ®Google Scholar
• Norris P G, Jones C JH, Weston M J. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Br Med J 1986; 293: 104–5
   PubMed Web of Science ®Google Scholar
• Knapp H R, FitzGerald G A. The antihypertensive effects of fish oil: a controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989; 320: 1037–43
   PubMed Web of Science ®Google Scholar
• Bønaa K, Bjerve K S, Straume B, Gram I T, Thelle D. Effects of eicosapentaenoic acid and docosahexaenoic acid on blood pressure in hypertension. N Engl J Med 1990; 322: 795–801
   PubMed Web of Science ®Google Scholar
• Bønaa K. Epidemiological and intervention studies on the effect of marine polyunsaturated fatty acids on blood pressure. J Intern Med 1989; 225(Suppl. 1)105–10
   Google Scholar
• von Schacky C, Fischer S, Weber P C. Long-term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985; 76: 1626–31
   PubMed Web of Science ®Google Scholar
• Saynor R, Gillott T. Fish oil and plasma fibrinogen. Br Med J 1988; 297: 1196
   PubMed Web of Science ®Google Scholar
• Saynor R, Gillott T. Fish oil revisited. Lancet 1989; ii: 810–1
   Google Scholar
• Dyerberg J, Bang H O. Hæmostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; i: 433–5
   Web of Science ®Google Scholar
• Solomon S A, Cartwright I, Pockley G, et al. A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectoris. Curr Med Res Opin 1990; 12: 1–11
   PubMed Web of Science ®Google Scholar
• Harris W S, Silveira S, Dujovne C A. The combined effects of n-3 fatty acids and aspirin on hemostatic parameters in man. Thromb Res 1990; 57: 517–26
   PubMed Web of Science ®Google Scholar
• Schmidt E B, Sørensen P J, Ernst E, Kristensen S D, Pedersen J O, Dyerberg J. Studies on coagulation and fibrinolysis in Greenland Eskimos. Thromb Res 1989; 56: 553–8
   PubMed Web of Science ®Google Scholar
• Schmidt E B, Ernst E, Varming K, Pedersen J O, Dyerberg J. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidaemia. Thromb Haemostas 1989; 62: 797–801
   PubMed Web of Science ®Google Scholar
• Schmidt E B, Nielsen L K, Pedersen J O, Kornerup H J, Dyerberg J. The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. Clin Chim Acta 1990; 189: 25–32
   PubMed Web of Science ®Google Scholar
• Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. JACC 1987; 9: 263–8
   Google Scholar
• Juhan-Vague I, Valadier J, Alessi M C, et al. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas 1987; 57: 67–72
   PubMed Web of Science ®Google Scholar
• Emeis J J, van Houwelingen A C, van den Hoogen C M, Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233–7
   PubMed Web of Science ®Google Scholar
• Boneu B, Abbal M, Plante J, Bierme R. Factor-VIII complex and endothelial damage. Lancet 1975; i: 1430
   Google Scholar
• Nilsson J, Elgue G, Wallin M, Hamsten A, Blombäck M. Correlation between plasma levels of growth factors and von Willebrand factor. Thromb Res 1989; 54: 125–32
   PubMed Web of Science ®Google Scholar
• Nichols T C, Bellinger D A, Tate D A, et al. Von Willebrand factor and occlusive arterial thrombosis. Arteriosclerosis 1990; 10: 449–61
   PubMedGoogle Scholar
• Schmidt E B, Varming K, Pedersen J O, Lervang H-H, Grunnet N, Jersild C, Dyerberg J. Longterm supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte chemotaxis. Scand J Clin Lab Invest 1992; 52: 229–36
   PubMed Web of Science ®Google Scholar